WHO: Coronavirus cases declining everywhere except Europe

LONDON – The World Health Organization reported Wednesday that coronavirus deaths rose by 10% in Europe in the past week, making it the only world region where both COVID-19 cases and deaths are steadily increasing. It was the sixth consecutive week that the virus has risen across the continent.

In its weekly report on the pandemic, the U.N. health agency said there were about 3.1 million new cases globally, about a 1% increase from the previous week. Nearly two-thirds of the coronavirus infections – 1.9 million – were in Europe, where cases rose by 7%.

The countries with the highest numbers of new cases worldwide were the United States, Russia, Britain, Turkey and Germany. The number of weekly COVID-19 deaths fell by about 4% worldwide and declined in every region except Europe.

Out of the 61 countries WHO includes in its European region, which includes Russia and stretches to Central Asia, 42% reported a jump in cases of at least 10% in the last week.

In the Americas, WHO said that new weekly cases fell by 5% and deaths declined by 14%, with the highest numbers reported from the United States.

On Tuesday, pharmaceutical company Pfizer asked the U.S. Food and Drug Administration to authorize booster shots of coronavirus vaccines for all adults. WHO has pleaded with countries not to administer more boosters until at least the end of the year; about 60 countries are actively rolling them out.

In Southeast Asia and Africa, COVID-19 deaths declined by about a third, despite the lack of vaccines in those regions.

WHO’s Europe director, Dr. Hans Kluge, said last week that Europe was once again “back at the epicenter of the pandemic.” He warned that if more actions weren’t taken to stop COVID-19, the region could see another 500,000 deaths by February.

  • Related Posts

    • Pharma
    • June 16, 2025
    • 94 views
    Natco API plant gets one observation from FDA

    Hyderabad: Drugmaker, Natco Pharma, Mekaguda-based Active Pharmaceutical Ingredients (API) plant has received one observation under the form 483 from the US Food and Drug Administration (FDA). In a stock exchange…

    • Pharma
    • June 16, 2025
    • 85 views
    Pharma department refuses to name 30 doctors in bribery tangle

    Thirty doctors who accepted foreign travel and hospitality worth Rs 1.9 crore from pharma company AbbVie in Feb-March 2024 have faced no action from NMC because the department of pharmaceuticals…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Natco API plant gets one observation from FDA

    Natco API plant gets one observation from FDA

    Pharma department refuses to name 30 doctors in bribery tangle

    Pharma department refuses to name 30 doctors in bribery tangle

    Delhi Police busts fake cancer drugs racket

    Delhi Police busts fake cancer drugs racket

    Sun Pharma appoints Kirti Ganorkar as the Managing Director

    Sun Pharma appoints Kirti Ganorkar as the Managing Director